8) Therapeutics
Abstract
CWA Operational Exposure Hazard Assessment Research: Supports FDA licensure of new compounds or new indications for licensed products for use in the treatment of chemical warfare casualties.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2011
- Source ID
- 32188e2c0da105bde5436ea9285b40a9